In vitro and in silico anti-malarial activity and cytotoxicity of n-hexyl 1-O-rutinoside (a glycoside) isolated from Annickia polycarpa (DC.) Setten and Maas ex I.M. Turner (Annonaceae).


Journal

Journal of ethnopharmacology
ISSN: 1872-7573
Titre abrégé: J Ethnopharmacol
Pays: Ireland
ID NLM: 7903310

Informations de publication

Date de publication:
30 Jan 2024
Historique:
received: 09 08 2023
revised: 27 09 2023
accepted: 04 10 2023
medline: 20 11 2023
pubmed: 13 10 2023
entrez: 12 10 2023
Statut: ppublish

Résumé

Annickia polycarpa leaf is an effective anti-malarial agent. However, its chemical constituents have not been isolated and assayed against any pathogen. To isolate and characterize anti-malarial compound(s) from the leaf of A. polycarpa. Bioassay-guided fractionation was employed to isolated the compound (AL1) from the chloroform fraction (ALCF) of the basified ethanol extract of A. polycarpa leaf (ALE). AL1 was characterized by LC-MS, 1D and 2D NMR spectroscopic analysis. Anti-malarial activity was evaluated against drug resistance Dd2 and drug sensitive 3D7 Plasmodium falciparum strains using the SYBR green assay. Cytotoxicity and mechanistic studies were determined using tetrazolium-based colorimetric assay and molecular docking respectively. AL1 was characterized as n-hexyl 1-O-rutinoside. The IC These results show that A. polycarpa leaf and n-hexyl 1-O-rutinoside possessed profound anti-malarial activity and are not cytotoxic. N-hexyl 1-O-rutinoside could therefore, be developed into a new anti-malarial medicine. This is the first study to report the anti-malarial activity of n-hexyl 1-O-rutinoside and its isolation from the genus Annickia.

Identifiants

pubmed: 37827299
pii: S0378-8741(23)01157-1
doi: 10.1016/j.jep.2023.117287
pii:
doi:

Substances chimiques

Antimalarials 0
Artesunate 60W3249T9M
Glycosides 0
Chloroquine 886U3H6UFF

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117287

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Emmanuel Kofi Kumatia (EK)

Department of Phytochemistry, Centre for Plant Medicine Research, Mampong-Akwapim, Ghana; Department of Quality Management, Centre for Plant Medicine Research, Mampong-Akwapim, Ghana. Electronic address: kofi2rhyme@yahoo.com.

Felix Kwame Zoiku (FK)

Depaertment of Epidemiology, Nouguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana. Electronic address: fzoiku@noguchi.ug.edu.gh.

Alex Asase (A)

Plant Development Department, Centre for Plant Medicine Research, Mampong-Akwapim, Ghana. Electronic address: alexasase22@gmail.com.

Nguyen Huu Tung (NH)

Faculty of Pharmacy, Phenikaa University, Hanoi 12116, Viet Nam. Electronic address: tung.nguyenhuu@phenikaa-uni.edu.vn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH